和邦生物
(603077)
| 流通市值：192.53亿 | | | 总市值：192.53亿 |
| 流通股本：88.32亿 | | | 总股本：88.32亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 7,244,794,642.39 | 6,815,968,668.4 | 6,698,975,052.48 | 6,821,397,689.82 |
| 应收票据及应收账款 | 647,309,732.72 | 810,097,041.48 | 624,267,253.5 | 1,058,656,332.41 |
| 应收账款 | 647,309,732.72 | 810,097,041.48 | 624,267,253.5 | 1,058,656,332.41 |
| 应收款项融资 | 575,004,443.3 | 175,708,957.59 | 350,670,396.62 | 654,758,043.28 |
| 预付款项 | 200,860,748.64 | 185,844,965.18 | 187,681,715.12 | 231,340,644.18 |
| 其他应收款合计 | 26,975,498.85 | 39,406,764.59 | 24,074,447.21 | 52,227,676.75 |
| 其中:应收利息 | - | - | - | 664,841.97 |
| 存货 | 4,305,105,848.49 | 4,210,719,625.7 | 3,909,353,584.58 | 4,059,944,815.9 |
| 合同资产 | 28,679,655.7 | 41,262,205.54 | 35,414,590.14 | 41,792,864.05 |
| 其他流动资产 | 115,525,534.8 | 190,898,285.55 | 193,941,479.66 | 154,217,850.48 |
| 流动资产合计 | 13,144,256,104.89 | 12,469,906,514.03 | 12,024,378,519.31 | 13,074,335,916.87 |
| 非流动资产: | | | | |
| 长期应收款 | 111,427,740.15 | 111,598,407.95 | 111,773,306.36 | 126,801,802.96 |
| 长期股权投资 | 120,145,357.48 | 121,906,146.96 | 124,638,872.38 | 111,281,486.73 |
| 其他权益工具投资 | 307,750,667.78 | 298,140,966.33 | 302,439,475.6 | 300,910,882.76 |
| 其他非流动金融资产 | 465,278,185.83 | 465,278,185.83 | 465,278,185.83 | 465,278,185.83 |
| 固定资产 | 6,263,574,576.76 | 6,378,566,019.32 | 7,368,526,645.82 | 7,320,764,473.17 |
| 在建工程 | 3,251,098,731.52 | 3,024,300,985 | 2,136,028,735.44 | 2,557,528,406.01 |
| 使用权资产 | 28,646,614.06 | 32,935,823.94 | 36,268,281.23 | 26,008,229.42 |
| 无形资产 | 2,816,930,493.79 | 2,837,075,383.36 | 2,849,903,551.03 | 2,667,283,619.46 |
| 开发支出 | 341,161,075.48 | 286,544,074.65 | 231,550,023.02 | 219,887,957.62 |
| 商誉 | 1,778,155,078.58 | 1,778,155,078.58 | 1,778,155,078.58 | 1,838,405,543.83 |
| 长期待摊费用 | 1,226,415.15 | - | 833,962.31 | 932,075.51 |
| 递延所得税资产 | 137,647,333.71 | 133,930,341.17 | 145,900,684.07 | 135,416,687.1 |
| 其他非流动资产 | 873,371,717.84 | 780,981,640.08 | 633,768,316.51 | 449,157,313.99 |
| 非流动资产合计 | 16,496,413,988.13 | 16,249,413,053.17 | 16,185,065,118.18 | 16,219,656,664.39 |
| 资产总计 | 29,640,670,093.02 | 28,719,319,567.2 | 28,209,443,637.49 | 29,293,992,581.26 |
| 流动负债: | | | | |
| 短期借款 | 645,440,666.65 | 1,328,783,908.31 | 2,308,058,808.27 | 2,551,846,935.61 |
| 应付票据及应付账款 | 884,644,797.82 | 801,475,502.33 | 930,521,860.04 | 983,530,792.19 |
| 应付账款 | 884,644,797.82 | 801,475,502.33 | 930,521,860.04 | 983,530,792.19 |
| 合同负债 | 93,284,804.68 | 179,963,929.91 | 129,715,572.1 | 149,419,399.88 |
| 应付职工薪酬 | 52,182,703.72 | 53,146,777.08 | 83,557,507.7 | 45,393,124.11 |
| 应交税费 | 77,040,693.88 | 55,677,541.7 | 29,491,548.1 | 61,783,461 |
| 其他应付款合计 | 16,202,389.42 | 20,022,719.84 | 18,897,223.58 | 25,771,453.61 |
| 一年内到期的非流动负债 | 900,171,062.75 | 781,581,328.21 | 274,438,927.53 | 434,594,174.61 |
| 其他流动负债 | 4,923,231.51 | 14,559,045.44 | 9,516,040.3 | 12,271,008.86 |
| 流动负债合计 | 2,673,890,350.43 | 3,235,210,752.82 | 3,784,197,487.62 | 4,264,610,349.87 |
| 非流动负债: | | | | |
| 长期借款 | 2,921,134,153.62 | 2,632,942,962.28 | 1,830,688,787.95 | 1,670,999,448.35 |
| 应付债券 | 4,341,279,220.45 | 4,309,851,239.78 | 4,278,635,022.35 | 4,261,462,536.39 |
| 租赁负债 | 19,554,033.15 | 20,593,040.05 | 21,955,450.29 | 13,893,934.57 |
| 预计负债 | 12,047,838.68 | 12,518,050.83 | 16,150,363.96 | - |
| 递延收益 | 144,319,776.29 | 144,760,934.25 | 145,154,871.75 | 127,361,577.64 |
| 递延所得税负债 | 183,777,972.5 | 181,616,734.45 | 173,781,489.84 | 190,150,045.19 |
| 非流动负债合计 | 7,622,112,994.69 | 7,302,282,961.64 | 6,466,365,986.14 | 6,263,867,542.14 |
| 负债合计 | 10,296,003,345.12 | 10,537,493,714.46 | 10,250,563,473.76 | 10,528,477,892.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 8,831,702,728 | 8,831,672,728 | 8,831,529,228 | 8,831,391,228 |
| 其他权益工具 | 364,149,441.29 | 364,154,192 | 364,176,916.23 | 364,198,769.49 |
| 资本公积 | 1,053,854,821.86 | 980,928,760.67 | 950,177,322.57 | 948,645,783.19 |
| 减:库存股 | 845,579,399.84 | 1,748,852,406.89 | 1,789,756,980.29 | 1,789,756,980.29 |
| 其他综合收益 | -73,445,404.76 | -59,018,890.3 | -39,923,982.7 | -27,505,698.84 |
| 专项储备 | 13,063,106.01 | 13,508,940.84 | 14,305,789.34 | 19,744,977.82 |
| 盈余公积 | 600,901,424.23 | 600,901,424.23 | 600,901,424.23 | 600,901,424.23 |
| 未分配利润 | 9,325,719,306.75 | 9,119,150,084.05 | 8,945,561,031.41 | 9,575,076,238.71 |
| 归属于母公司股东权益合计 | 19,270,366,023.54 | 18,102,444,832.6 | 17,876,970,748.79 | 18,522,695,742.31 |
| 少数股东权益 | 74,300,724.36 | 79,381,020.14 | 81,909,414.94 | 242,818,946.94 |
| 股东权益合计 | 19,344,666,747.9 | 18,181,825,852.74 | 17,958,880,163.73 | 18,765,514,689.25 |
| 负债和股东权益合计 | 29,640,670,093.02 | 28,719,319,567.2 | 28,209,443,637.49 | 29,293,992,581.26 |
| 公告日期 | 2026-08-18 | 2026-04-21 | 2026-04-21 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |